Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
North America (Primary) | PRIMARYNOAM | Univ | 8,182 | 57,752,183 | 1.17% | 0.69% | -0.55% | 3.20% | 17.21% | 22.70% |
Healthcare | HEALTHCARE | Sector | 1,343 | 6,388,469 | 0.29% | 1.41% | -0.56% | -1.12% | 15.27% | 9.49% |
Biopharmaceuticals | BIOPHARMA | SubSec | 680 | 2,955,318 | -1.30% | 2.27% | -3.22% | -4.19% | 22.01% | 22.67% |
System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 308 | 1,511,979 | -0.59% | 2.10% | -2.46% | -2.28% | 20.73% | 10.62% |
Immunology Biopharmaceuticals | IMMUNOLOGY | SubInd | 30 | 310,500 | 1.73% | 2.94% | -0.78% | -5.04% | 21.57% | 18.29% |
Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
Alpine Immune Sciences, Inc. | ALPN:USAALPN:USA | Stock | 1 | 3,898 | 0.00% | 0.06% | 82.85% | 135.34% | 338.86% | 844.44% |
Vera Therapeutics, Inc. | VERA:USAVERA:USA | Stock | 1 | 1,931 | -0.14% | 9.56% | 16.12% | 17.37% | 333.10% | 497.52% |
TG Therapeutics, Inc. | TGTX:USATGTX:USA | Stock | 1 | 2,452 | -1.40% | 20.19% | 11.96% | 5.75% | 55.52% | -53.74% |
Kiniksa Pharmaceuticals Ltd. | KNSA:USAKNSA:USA | Stock | 1 | 1,334 | 3.61% | 12.30% | 11.18% | 8.60% | 25.89% | 48.08% |
Pharvaris NV | PHVS:USAPHVS:USA | Stock | 1 | 1,182 | -3.95% | -3.21% | 0.76% | -29.53% | 31.55% | 150.28% |
Aurinia Pharmaceuticals, Inc. | AUPH:USAAUPH:USA | Stock | 1 | 733 | -1.35% | 3.87% | 0.20% | -32.45% | -35.28% | -55.03% |
S&P 500 | SPY:USASPY:USA | Benchmark | 14,775 | 75,192,730 | 1.24% | 0.60% | -0.35% | 4.13% | 19.55% | 28.03% |
Immunology Biopharmaceuticals | IMMUNOLOGY | SubInd | 30 | 310,500 | 1.73% | 2.94% | -0.78% | -5.04% | 21.57% | 18.29% |
AbbVie, Inc. | ABBV:USAABBV:USA | Stock | 1 | 289,208 | 1.85% | 2.61% | -1.54% | -3.47% | 16.50% | 15.66% |
BioCryst Pharmaceuticals, Inc. | BCRX:USABCRX:USA | Stock | 1 | 916 | -0.67% | 6.97% | -3.26% | -13.42% | -21.10% | -47.46% |
Viridian Therapeutics, Inc. | VRDN:USAVRDN:USA | Stock | 1 | 831 | 5.62% | 19.57% | -5.64% | -17.65% | 9.37% | -43.90% |
Immunovant, Inc. | IMVT:USAIMVT:USA | Stock | 1 | 4,187 | 0.28% | 6.22% | -6.42% | -21.17% | -12.78% | 51.89% |
Cabaletta Bio, Inc. | CABA:USACABA:USA | Stock | 1 | 593 | -1.67% | 12.53% | -23.09% | -45.10% | -20.27% | 1.47% |
Kyverna Therapeutics, Inc. | KYTX:USAKYTX:USA | Stock | 1 | 658 | 1.46% | -1.42% | -31.61% | N/A | N/A | N/A |
* Colors indicate performance relative to the benchmark.